GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in GeoVax Labs, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −2 vs. Q2 2023
- Shares held
- 1.55M
- −59.5K (−3.7%) vs. Q2 2023
- Total value
- $797.6K
- −$88.4K (−10.0%) vs. Q2 2023
- New holders
- 1
- 2 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 728,443 | $374.4K | 0.00% | −2,542−0.3% | Reduced |
| BlackRock Inc. | 413,444 | $212.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 172,895 | $88.9K | 0.00% | +145+0.1% | Added |
| State Street Corp | 97,942 | $50.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 50,197 | $25.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 34,214 | $17.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 19,019 | $9.78K | 0.00% | +18,294+2,523.3% | Added |
| Welch & Forbes LLC | 16,994 | $8.73K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,504 | $5.40K | 0.00% | −58−0.5% | Reduced |
| Wells Fargo & Company | 4,568 | $2.35K | 0.00% | −122−2.6% | Reduced |
| Advisor Group Holdings, Inc. | 3,000 | $1.54K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 401 | $217 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 32 | $16 | 0.00% | +32 | New |
| Royal Bank of Canada | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −36,805−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −27,097−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,328−100.0% | Sold out |